Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables: 2009-2025

Historic Payables for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $2.0 million.

  • Rockwell Medical's Payables fell 35.47% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 44.69%. This contributed to the annual value of $3.1 million for FY2024, which is 34.10% down from last year.
  • Rockwell Medical's Payables amounted to $2.0 million in Q3 2025, which was down 8.19% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Payables registered a high of $6.7 million during Q2 2023, and its lowest value of $2.0 million during Q3 2025.
  • Moreover, its 3-year median value for Payables was $4.0 million (2024), whereas its average is $3.8 million.
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 49.63% in 2023, then plummeted by 59.50% in 2025.
  • MRQ analysis of 5 years shows Rockwell Medical's Payables stood at $4.2 million in 2021, then grew by 9.10% to $4.6 million in 2022, then grew by 4.48% to $4.8 million in 2023, then plummeted by 34.10% to $3.1 million in 2024, then plummeted by 36.72% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.2 million for Q2 2025, and $2.0 million during Q1 2025.